
    
      The aim of the study is to demonstrate the non-inferiority of Eyestil Plus® compared to
      Vismed Multi® in terms of clinical performance as detected by a reduction of keratitis
      lesions objectified by staining tests after 1 month of treatment, in patients with moderate
      to severe dry eye syndrome with keratoconjunctivitis. Secondly, the study is aimed at
      evaluating the safety profile of the product and the patients' quality of life.
    
  